Icon close



COVID-19 Vaccine Rollout

From the earliest days of COVID-19, King & Spalding has been at the forefront of vaccine developments, helping our leading pharmaceutical clients develop and implement strategies to contain the legal and reputational risks throughout their journey.  At this critical juncture of distribution, our COVID-19 Vaccine Rollout Task Force is drawing on our industry knowledge and client relationships to serve as a guiding light and partner to our clients.  

As you will see in the resources herein, we are focused on untangling the matrix of hurdles that arise in this unchartered landscape of developing state guidance intersecting with a rapidly evolving federal landscape.  We are also examining the legislation developing to advise clients on immunity provisions and helping our clients prepare for potential investigations and litigation to follow. 

Read more

Federal and State Survey of COVID-19 Vaccine Updates

This survey provides COVID-19 vaccine status, guidance, laws and regulations, and other legal developments.

Read More

COVID-19 Vaccine Updates

This blog provides regular updates on COVID-19 vaccine-related developments.

Read More

COVID-19 Survey of Federal and State Price Gouging Laws

In response to the ongoing COVID-19 pandemic, the U.S. government, many states, and even some counties and municipalities have invoked emergency powers and issued a variety of executive-level orders to protect the public health.

Read More

Related Lawyers

John P. Hooper New York
Jeffrey S. Spigel (Jeff) Washington, D.C.
Ethan P. Davis San Francisco
David L. Balser Atlanta
Nikki Reeves Washington, D.C.
Mark D. Polston Washington, D.C.